WILLIAM J. LINK PHD - 10 Nov 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Other	$0	-215,575	-33%	$0.000000	431,151	10 Nov 2022	By Flying L Investments XI, LLC	F1, F2
transaction	TARS	Common Stock	Other	$0	+8,382	+104%	$0.000000	16,479	10 Nov 2022	By Flying L Partners XI, LLC	F3, F4
holding	TARS	Common Stock						134,632	10 Nov 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC.
F2	The shares are held directly held by Flying L Investments XI, LLC. The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
F3	Represents the receipt of shares from a pro-rata in-kind distribution and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners.
F4	The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.